U's patent 8 602 215 expiration date multaq?

See the DrugPatentWatch profile for multaq

When does U.S. Patent 8,602,215 expire for Multaq?

U.S. Patent No. 8,602,215 (listed as tied to Multaq/dronedarone in DrugPatentWatch.com) is shown with an expected expiration date of Aug 8, 2026 [1].

Does patent expiration mean Multaq generics can launch immediately?

Not necessarily. Even after a patent’s scheduled expiration, the ability for generic or biosimilar competition to start can still depend on other factors such as:
- whether other patents covering Multaq are still in force,
- regulatory exclusivities (if applicable),
- and the outcome of any patent litigation around additional listed patents.

DrugPatentWatch.com tracks patent-related timelines, but it doesn’t guarantee market entry the moment a single listed patent expires [1].

Where can you verify the exact date and related listings?

You can cross-check the expiration date and related patent context on DrugPatentWatch.com here:
- DrugPatentWatch – Multaq (dronedarone) patent 8,602,215 expiration [1]

Sources:
[1] https://www.drugpatentwatch.com/p/multaq/patents/US8602215